CRL introduced TURBOFLEX, a glass railing system. TURBOFLEX enables glaziers to save time during the railing installation process while achieving adjustability and performance. The new railing system ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Wilmington, Massachusetts-based Charles River Laboratories International, Inc. (CRL) provides drug discovery, non-clinical ...
Zacks Investment Research on MSN
Will Charles River (CRL) beat estimates again in its next earnings report?
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain ...
ClearBridge Investments, a global equity manager, recently published first-quarter 2026 commentary for its “Small Cap Growth Strategy”. A copy of the letter can be downloaded here. The beginning of ...
While Charles River Laboratories has underperformed its sector peers recently, analysts remain moderately optimistic about ...
Replimune Group, Inc. stock drops after a second FDA rejection for RP1 melanoma; cash runway <12 months. Click for more on ...
Although no safety or manufacturing concerns were identified, the agency raised questions regarding the reliability of clinical findings due to inconsistent trial results. The Food and Drug ...
Patients received an initial intratumoral injection of RP1 with up to 7 additional doses every 2 weeks, plus 240 mg nivolumab ...
Opinion
FDA Issues CRL to Replimune for RP1 Biologics License Application for Advanced Melanoma Treatment
Replimune received a second FDA complete response letter for RP1 in advanced melanoma, raising questions about the viability of its oncolytic immunotherapy program. Replimune Group received a complete ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results